|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ch. 84
|
|
2000 LAWS OF MARYLAND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(I) FOR PARENTS, TEACHERS, CHILD CARE PROVIDERS, AND
PRIMARY CARE PHYSICIANS; AND
(II) TO EXAMINE THE LATEST INFORMATION ON;
1. ATTENTION DEFICIT HYPERACTIVITY DISORDER;
2. THE USE OF MEDICATIONS EFFECTIVE IN THE
TREATMENT OF THE DISORDER; AND
3. NONPHARMACOLOGICAL INTERVENTIONS IN THE
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER;
(3) (2) SHALL REVIEW THE RELEVANT LITERATURE AND CURRENT
RESEARCH, INCLUDING PROFESSIONAL SOCIETY PRACTICE GUIDELINES;
(4) (3) MAY CONDUCT SURVEYS ON THE EXTENT OF ATTENTION
DEFICIT HYPERACTIVITY DISORDER AND THE POLICIES AND TREATMENTS USED IN
TREATING THE DISORDER;
(5) (4) SHALL ASSIST ALL LOCAL SCHOOL SYSTEMS IN DESIGNING
AND IMPLEMENTING WRITTEN GUIDELINES FOR THE OPTIMAL DIAGNOSIS AND
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER, FOLLOWING "BEST
PRACTICES" WHILE COMPLYING WITH FEDERAL REQUIREMENTS;
(6) (5) SHALL DEVELOP AND DISTRIBUTE EDUCATIONAL PROGRAMS
AND MATERIALS CONCERNING ATTENTION DEFICIT HYPERACTIVITY DISORDER TO
PARENTS, EDUCATORS, CHILD CARE PROVIDERS, AND PRIMARY CARE PHYSICIANS;
(7) (6) SHALL ASSIST THE GOVERNOR AND STATE AGENCIES IN
IMPLEMENTING THE RECOMMENDATIONS OF THE MARCH 1999 REPORT OF THE TASK
FORCE TO STUDY THE USES OF METHYLPHENIDATE AND OTHER DRUGS ON SCHOOL
CHILDREN INCLUDING PERFORMING THE FOLLOWING TASKS:
(I) FACILITATING COMMUNICATION BETWEEN PHYSICIANS,
EDUCATORS, AND PARENTS;
(II) PROVIDING ONGOING TRAINING FOR PRIMARY CARE
PROVIDERS, FAMILIES, EDUCATORS, AND SCHOOL HEALTH PERSONNEL;
(III) PROVIDING SUPPORT FOR CONTINUED RESEARCH AND
EVALUATION;
(IV) PROVIDING SUPPORT FOR FAMILIES INCLUDING INCREASED
ACCESS TO RESOURCES;
(V) PROMOTING SMALLER CLASS SIZES FOR CHILDREN WITH
ATTENTION DEFICIT HYPERACTIVITY DISORDER;
(VI) PROMOTING THE PRESENCE OF A MENTAL HEALTH EXPERT
WHO IS KNOWLEDGEABLE ABOUT ATTENTION DEFICIT HYPERACTIVITY DISORDER
IN EACH SCHOOL SYSTEM; AND
|
|
|
|
|
|
|
|
|
|
- 672 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
